Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 0.78.

  • Firefly Neuroscience's Equity Ratio rose 24896.66% to 0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78, marking a year-over-year increase of 24896.66%. This contributed to the annual value of 0.08 for FY2024, which is 29747.9% down from last year.
  • Per Firefly Neuroscience's latest filing, its Equity Ratio stood at 0.78 for Q3 2025, which was up 24896.66% from 0.81 recorded in Q2 2025.
  • Over the past 5 years, Firefly Neuroscience's Equity Ratio peaked at 0.81 during Q2 2025, and registered a low of 0.52 during Q3 2024.
  • Moreover, its 5-year median value for Equity Ratio was 0.42 (2023), whereas its average is 0.31.
  • In the last 5 years, Firefly Neuroscience's Equity Ratio plummeted by 29747.9% in 2024 and then skyrocketed by 1764346.64% in 2025.
  • Firefly Neuroscience's Equity Ratio (Quarter) stood at 0.75 in 2021, then tumbled by 137.36% to 0.28 in 2022, then surged by 114.8% to 0.04 in 2023, then tumbled by 297.48% to 0.08 in 2024, then soared by 1054.98% to 0.78 in 2025.
  • Its Equity Ratio stands at 0.78 for Q3 2025, versus 0.81 for Q2 2025 and 0.42 for Q1 2025.